Literature DB >> 28202093

Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysis.

M A Huaman1, R J Kryscio2, C J Fichtenbaum1, D Henson3, E Salt4, T R Sterling5, B A Garvy3.   

Abstract

Several pathogens have been associated with increased cardiovascular disease (CVD) risk. Whether this occurs with Mycobacterium tuberculosis infection is unclear. We assessed if tuberculosis disease increased the risk of acute myocardial infarction (AMI). We identified patients with tuberculosis index claims from a large de-identified database of ~15 million adults enrolled in a U.S. commercial insurance policy between 2008 and 2010. Tuberculosis patients were 1:1 matched to patients without tuberculosis claims using propensity scores. We compared the occurrence of index AMI claims between the tuberculosis and non-tuberculosis cohorts using Kaplan-Meier curves and Cox Proportional Hazard models. Data on 2026 patients with tuberculosis and 2026 propensity-matched patients without tuberculosis were included. AMI was more frequent in the tuberculosis cohort compared with the non-tuberculosis cohort, 67 (3·3%) vs. 32 (1·6%) AMI cases, respectively, P < 0·01. Tuberculosis was associated with an increased risk of AMI (adjusted hazard ratio (HR) 1·98, 95% confidence intervals (CI) 1·3-3·0). The results were similar when the analysis was restricted to pulmonary tuberculosis (adjusted HR 2·43, 95% CI 1·5-4·1). Tuberculosis was associated with an increased risk of AMI. CVD risk assessment should be considered in tuberculosis patients. Mechanistic studies of tuberculosis and CVD are warranted.

Entities:  

Keywords:  Acute myocardial infarction; cardiovascular disease; risk; tuberculosis

Mesh:

Year:  2017        PMID: 28202093      PMCID: PMC5616129          DOI: 10.1017/S0950268817000279

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

Review 1.  Sudden cardiac death and tuberculosis - how much do we know?

Authors:  Alexander Liu; Yanmin Hu; Anthony Coates
Journal:  Tuberculosis (Edinb)       Date:  2012-03-08       Impact factor: 3.131

Review 2.  Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis.

Authors:  M E Rosenfeld; L A Campbell
Journal:  Thromb Haemost       Date:  2011-10-20       Impact factor: 5.249

3.  Risk Factors for Targeted Fungal and Mycobacterial Infections in Patients Taking Tumor Necrosis Factor Inhibitors.

Authors:  Elizabeth Salt; Amanda T Wiggins; Mary Kay Rayens; Moises A Huaman; David Mannino; Philip Schwieterman; Scott A Merkley; Allison R Jones; Leslie J Crofford
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

4.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

Review 5.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

Review 6.  Insights into the role of infection in atherogenesis and in plaque rupture.

Authors:  Stephen E Epstein; Jianhui Zhu; Amir H Najafi; Mary S Burnett
Journal:  Circulation       Date:  2009-06-23       Impact factor: 29.690

7.  Tuberculosis increases the subsequent risk of acute coronary syndrome: a nationwide population-based cohort study.

Authors:  W-S Chung; C-L Lin; C-T Hung; Y-H Chu; F-C Sung; C-H Kao; J-J Yeh
Journal:  Int J Tuberc Lung Dis       Date:  2014-01       Impact factor: 2.373

8.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis.

Authors:  Q Xu; J Willeit; M Marosi; R Kleindienst; F Oberhollenzer; S Kiechl; T Stulnig; G Luef; G Wick
Journal:  Lancet       Date:  1993-01-30       Impact factor: 79.321

9.  Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study.

Authors:  Jau-Jiuan Sheu; Hung-Yi Chiou; Jiunn-Horng Kang; Yi-Hua Chen; Herng-Ching Lin
Journal:  Stroke       Date:  2009-12-24       Impact factor: 7.914

10.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

Authors:  Peter C Austin
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

View more
  18 in total

1.  Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis.

Authors:  Knut A Hestad; Jonathan Chinyama; Menon J Anitha; Mary S Ngoma; J Allen McCutchan; Donald R Franklin; Robert K Heaton
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

2.  The Relationship Between Latent Tuberculosis Infection and Acute Myocardial Infarction.

Authors:  Moises A Huaman; Eduardo Ticona; Gustavo Miranda; Richard J Kryscio; Raquel Mugruza; Ernesto Aranda; Paola L Rondan; David Henson; Cesar Ticona; Timothy R Sterling; Carl J Fichtenbaum; Beth A Garvy
Journal:  Clin Infect Dis       Date:  2018-03-05       Impact factor: 9.079

Review 3.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

4.  Increased Mortality After Tuberculosis Treatment Completion in Persons Living With Human Immunodeficiency Virus in Latin America.

Authors:  Serena P Koenig; Ahra Kim; Bryan E Shepherd; Carina Cesar; Valdilea Veloso; Claudia P Cortes; Denis Padgett; Brenda Crabtree-Ramírez; Eduardo Gotuzzo; Catherine C McGowan; Timothy R Sterling; Jean W Pape
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

5.  Submission for Special Issue: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis, and Pneumococcal Disease. Bedaquiline Suppresses ADP-Mediated Activation of Human Platelets In Vitro via Interference With Phosphatidylinositol 3-Kinase.

Authors:  Gregory R Tintinger; Annette J Theron; Helen C Steel; Moloko C Cholo; Jan G Nel; Charles Feldman; Ronald Anderson
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

6.  Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro.

Authors:  Ronald Anderson; Annette J Theron; Jan G Nel; Chrisna Durandt; Moloko C Cholo; Charles Feldman; Gregory R Tintinger
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

7.  Pyrazinamide may possess cardioprotective properties.

Authors:  Sharabh Sinha; Qingyou Du; Sofija Jovanović; Andriy Sukhodub; Aleksandar Jovanović
Journal:  J Antibiot (Tokyo)       Date:  2019-06-27       Impact factor: 2.649

8.  Clinical impact of cardiovascular disease on patients with bronchiectasis.

Authors:  Shanshan Chen; Aimin Qiu; Zhang Tao; Hailin Zhang
Journal:  BMC Pulm Med       Date:  2020-04-23       Impact factor: 3.317

9.  Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda.

Authors:  Moises A Huaman; Carlo N De Cecco; Marcio S Bittencourt; Eduardo Ticona; Cissy Kityo; Isabel Ballena; Sophie Nalukwago; Rashidah Nazzinda; Cesar Ticona; Ruben Azañero; Bin Zhang; Carey Farquhar; Thomas R Hawn; Timothy R Sterling; Carl J Fichtenbaum; Chris T Longenecker
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

10.  Long-term mortality after tuberculosis treatment among persons living with HIV in Haiti.

Authors:  Yvetot Joseph; Zhiwen Yao; Akanksha Dua; Patrice Severe; Sean E Collins; Heejung Bang; Marc Antoine Jean-Juste; Oksana Ocheretina; Alexandra Apollon; Margaret L McNairy; Kathryn Dupnik; Etienne Cremieux; Anthony Byrne; Jean W Pape; Serena P Koenig
Journal:  J Int AIDS Soc       Date:  2021-07       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.